Erasca, Inc. (ERAS)
3.535
+0.08
(+2.17%)
USD |
NASDAQ |
Dec 30, 16:00
3.535
0.00 (0.00%)
After-Hours: 20:00
Erasca EPS Diluted (Quarterly): -0.1079 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| GT Biopharma, Inc. | -0.8268 |
| ALX Oncology Holdings, Inc. | -0.4133 |
| Prelude Therapeutics, Inc. | -0.2591 |
| Foghorn Therapeutics, Inc. | -0.2514 |
| Atea Pharmaceuticals, Inc. | -0.5319 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -30.61M |
| Total Expenses (Quarterly) | 30.61M |
| Enterprise Value | 741.54M |
| Earnings Yield | -12.75% |
| Normalized Earnings Yield | -12.09 |